|
TD-5108 is a highly selective serotonin receptor agonist effective in patients with chronic constipation. It is being developed by Theravance. TD-5108 was discovered by Theravance through the application of its multivalent drug design in a research program dedicated to finding new treatments for GI motility disorders.
|
